Earnings Outlook For Ginkgo Bioworks Holdings
Portfolio Pulse from Benzinga Insights
Ginkgo Bioworks Holdings (NYSE:DNA) is scheduled to release its quarterly earnings report on Thursday, 2024-02-29, with an expected EPS of $-0.10. Investors are hopeful for a beat on this estimate and positive guidance for the next quarter. The company's past earnings performance shows a pattern of not meeting EPS estimates, leading to significant price drops. Shares are currently trading at $1.53, with a 9.28% increase over the last 52 weeks.
February 28, 2024 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ginkgo Bioworks Holdings is anticipated to report an EPS of $-0.10 for the quarter. Historical performance shows sensitivity to earnings reports, with past misses leading to price declines.
Given Ginkgo Bioworks Holdings' history of not meeting EPS estimates and the subsequent negative impact on its stock price, there is a high likelihood of a short-term negative impact if the company fails to meet or exceed the expected EPS of $-0.10. The pattern of price drops following earnings misses suggests a sensitive investor response to earnings performance.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100